1,2-distearoylphosphatidylethanolamine has been researched along with stilbenes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrajón-Catalán, E; Catania, A; Cicirata, F; Micol, V; Nicolosi, S | 1 |
| Du, J; Li, C; Liu, Y; Wang, L; Wang, Y; Zhao, J; Zhou, Y | 1 |
2 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and stilbenes
| Article | Year |
|---|---|
Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells.
Topics: Antibodies, Monoclonal, Humanized; Anticarcinogenic Agents; Antineoplastic Agents; Biological Availability; Biological Products; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Cell Line, Tumor; Cholesterol; Chromatography, High Pressure Liquid; Curcumin; Drug Compounding; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Immunoconjugates; Liposomes; Neoplasm Proteins; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Receptor, ErbB-2; Resveratrol; Stilbenes; Trastuzumab | 2013 |
In vitro and in vivo evaluation of targeting tumor with folate-based amphiphilic multifunctional stabilizer for resveratrol nanosuspensions.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Drug Delivery Systems; Drug Stability; Folic Acid; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron; Nanoparticles; Phosphatidylethanolamines; Polyethylene Glycols; Resveratrol; Stilbenes; Suspensions; Xenograft Model Antitumor Assays | 2017 |